These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39151716)

  • 1. microRNA profiling of exosomes derived from plasma and their potential as biomarkers for Opisthorchis viverrini-associated cholangiocarcinoma.
    Supradit K; Wongprasert K; Tangphatsornruang S; Yoocha T; Sonthirod C; Pootakham W; Thitapakorn V; Butthongkomvong K; Phanaksri T; Kunjantarachot A; Klongprateeppon H; Sattavacharavech P; Prasopdee S
    Acta Trop; 2024 Oct; 258():107362. PubMed ID: 39151716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
    Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
    Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional analysis of mitogenic miRNA of the carcinogenic liver fluke Opisthorchis viverrini.
    Tan S; Thanan R; Sripa B; Suttiprapa S
    Acta Trop; 2024 Aug; 256():107243. PubMed ID: 38719083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation of Plasma Cell-Free DNA and MiRNA in Cholangiocarcinoma and Opisthorchiasis Viverrini Patients.
    Prasopdee S; Pholhelm M; Yusuk S; Tangphatsornruang S; Butthongkomvong K; Kunjantarachot A; Phanaksri T; Kulsantiwong J; Tesana S; Thitapakorn V
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):739-746. PubMed ID: 38546056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opisthorchis viverrini: Gene expression profiling of carcinogenic adult liver fluke worms using 5' SAGE.
    Chutiwitoonchai N; Shen Y; Zheng H; Xiong H; Zhao G; Imtawil K; Intapan PM; Wongkham S; Wongkham C
    Exp Parasitol; 2008 Dec; 120(4):306-13. PubMed ID: 18786530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasis-associated cholangiocarcinoma.
    Akai PS; Pungpak S; Chaicumpa W; Viroj K; Bunnag D; Befus AD
    Trans R Soc Trop Med Hyg; 1994; 88(4):471-4. PubMed ID: 7570848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.
    Rodpai R; Luvira V; Sadaow L; Sukeepaisarnjaroen W; Kitkhuandee A; Paonariang K; Sanpool O; Ittiprasert W; Mann VH; Intapan PM; Brindley PJ; Maleewong W
    Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities.
    Kafle A; Suttiprapa S; Muhammad M; Tenorio JCB; Mahato RK; Sahimin N; Loong SK
    PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012477. PubMed ID: 39236081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma.
    Botelho MC; Alves H; Richter J
    Parasitol Res; 2016 Jul; 115(7):2913-4. PubMed ID: 27130317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Protein Expression Marks the Transition From Infection With
    Khoontawad J; Pairojkul C; Rucksaken R; Pinlaor P; Wongkham C; Yongvanit P; Pugkhem A; Jones A; Plieskatt J; Potriquet J; Bethony J; Pinlaor S; Mulvenna J
    Mol Cell Proteomics; 2017 May; 16(5):911-923. PubMed ID: 28232516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.
    Kitdumrongthum S; Metheetrairut C; Charoensawan V; Ounjai P; Janpipatkul K; Panvongsa W; Weerachayaphorn J; Piyachaturawat P; Chairoungdua A
    Life Sci; 2018 Oct; 210():65-75. PubMed ID: 30165035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Differentiation of
    Buathong S; Phaiphilai K; Ruang-Areerate T; Sitthichot N; Thita T; Mungthin M; Suwannahitatorn P
    Am J Trop Med Hyg; 2020 Sep; 103(3):1118-1124. PubMed ID: 32588808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
    Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtle to severe hepatobiliary morbidity in Opisthorchis viverrini endemic settings in southern Laos.
    Ayé Soukhathammavong P; Rajpho V; Phongluxa K; Vonghachack Y; Hattendorf J; Hongvanthong B; Rasaphon O; Sripa B; Akkhavong K; Hatz C; Odermatt P
    Acta Trop; 2015 Jan; 141(Pt B):303-9. PubMed ID: 25275346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
    Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.
    Chaiyarit P; Sithithaworn P; Thuwajit C; Yongvanit P
    Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Cell-Free DNA and MiRNA in Cholangiocarcinoma and Opisthorchiasis Viverrini Patients: Comment.
    Mungmunpuntipantip R; Wiwanitkit V
    Asian Pac J Cancer Prev; 2024 Aug; 25(8):2579. PubMed ID: 39205552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.